What is the sepsis protocol for a patient presenting with sepsis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sepsis Protocol

Treat sepsis as a medical emergency requiring immediate resuscitation with 30 mL/kg of crystalloid fluids within the first 3 hours, followed by early broad-spectrum antibiotics and continuous hemodynamic reassessment targeting a mean arterial pressure ≥65 mmHg. 1

Immediate Recognition and Risk Stratification

  • Calculate NEWS2 score to stratify risk of severe illness or death: 1
    • Score ≥7 indicates high risk
    • Score 5-6 indicates moderate risk
    • Score <5 indicates low risk
  • Immediately evaluate for red flags regardless of NEWS2 score: mottled or ashen appearance, non-blanching petechial/purpuric rash, cyanosis of skin/lips/tongue 1
  • Identify tissue hypoperfusion through: hypotension (systolic BP <90 mmHg), elevated lactate (≥4 mmol/L), altered mental status, decreased urine output, or delayed capillary refill 1, 2

Initial Resuscitation Bundle (First 3 Hours)

Fluid Resuscitation

  • Administer 30 mL/kg of crystalloid fluid within 3 hours as the fixed initial bolus 1, 2
  • Use balanced crystalloids (Ringer's Lactate or Plasma-Lyte) preferentially over 0.9% NaCl to reduce hyperchloremic acidosis risk 3
  • Many patients require >4 L in the first 24 hours; continue aggressive fluid administration for 24-48 hours guided by reassessment 1

Antibiotic Administration

  • High-risk patients (NEWS2 ≥7): Administer broad-spectrum antibiotics within 1 hour of recognition 1, 3
  • Moderate-risk patients (NEWS2 5-6): Administer within 3 hours 1
  • Low-risk patients: Administer within 6 hours 1
  • Source control should be identified and addressed urgently 1

Hemodynamic Targets and Monitoring

Primary Resuscitation Goals

  • Mean arterial pressure (MAP) ≥65 mmHg as initial target 1, 2
  • Lactate normalization as marker of tissue perfusion 1, 2
  • Urine output ≥0.5 mL/kg/hour 1, 3
  • Clinical signs of adequate perfusion: improved mental status, warm extremities, capillary refill <3 seconds 1

Reassessment Frequency

  • Every 30 minutes for high-risk patients 1
  • Every hour for moderate-risk patients 1
  • Continuous evaluation of heart rate, blood pressure, oxygen saturation, respiratory rate, temperature, and urine output 1

Fluid Responsiveness Assessment

The 2016 Surviving Sepsis Campaign guidelines represent a critical shift away from static measurements like CVP and ScvO2, which failed to show mortality benefit in three large RCTs (PROCESS, ARISE, PROMISE). 1 This evolution reflects that earlier EGDT protocols targeted sicker populations than typically encountered. 1

  • Use dynamic variables over static variables to predict fluid responsiveness: pulse pressure variation, stroke volume variation, passive leg raise test 1, 3
  • Do NOT use CVP alone to guide fluid resuscitation—it has limited predictive value (positive predictive value ~50%) and cannot reliably predict fluid responsiveness in the 8-12 mmHg range 1, 3
  • Perform frequent clinical reassessment including thorough examination and available physiologic variables 1
  • Consider echocardiography to assess cardiac function and determine shock type if clinical examination is unclear 1

Vasopressor Therapy

  • Initiate norepinephrine as first-line vasopressor if hypotension persists after adequate fluid resuscitation 3
  • Target MAP ≥65 mmHg initially, though some patients may require higher targets based on baseline blood pressure 1, 2
  • Epinephrine dosing (if used): 0.05-2 mcg/kg/min IV infusion, titrated every 10-15 minutes to achieve desired MAP 4
  • Consider dobutamine if evidence of myocardial dysfunction or persistent hypoperfusion despite adequate volume status 2

Critical Pitfalls to Avoid

  • Do not delay resuscitation waiting for ICU admission or central line placement—begin immediately upon recognition 1
  • Do not rely solely on CVP or ScvO2 targets from older EGDT protocols, as these have not shown mortality benefit in recent trials 1, 5
  • Do not use hydroxyethyl starch for resuscitation—it increases acute kidney injury and mortality risk 3
  • Do not withhold fluids due to fear of overload during initial resuscitation, but reassess frequently to avoid excessive administration 1, 3
  • Do not use low-dose dopamine for renal protection—it is ineffective 3
  • Do not delay antibiotics to obtain cultures if this causes significant delay; blood cultures should ideally be drawn before antibiotics but not delay administration 1

Ongoing Management Beyond Initial Hours

  • Review antibiotic choice within 1 hour of microbiological results, narrowing spectrum when appropriate 1
  • Wean vasopressors incrementally over 12-24 hours after hemodynamic stabilization 4
  • Monitor for complications: acute respiratory distress syndrome, acute kidney injury, coagulopathy 5
  • Transition to restrictive fluid strategy after initial resuscitation to avoid fluid overload 3, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Reanimación Hemodinámica Guiada por Metas en UCI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Paroxysmal Supraventricular Tachycardia in Sepsis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.